19674382

Source:http://linkedlifedata.com/resource/pubmed/id/19674382

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C1269683
pubmed:issue	5
pubmed:dateCreated	2009-9-30
pubmed:abstractText	The remission rates for patients with major depressive disorder (MDD) during algorithm-guided treatment (AGT), which consisted of four treatment strategy steps were prospectively compared with treatment as usual (TAU).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9513551
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Lithium Compounds
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1440-1819
pubmed:author	pubmed-author:KobayashiNobuhisaN, pubmed-author:KurauchiSachiS, pubmed-author:MatsumotoAkiA, pubmed-author:NomuraSoichiroS, pubmed-author:SawamuraTakehitoT, pubmed-author:YoshinoAihideA
pubmed:issnType	Electronic
pubmed:volume	63
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	652-7
pubmed:meshHeading	pubmed-meshheading:19674382-Algorithms, pubmed-meshheading:19674382-Antidepressive Agents, pubmed-meshheading:19674382-Depressive Disorder, Major, pubmed-meshheading:19674382-Drug Therapy, Combination, pubmed-meshheading:19674382-Female, pubmed-meshheading:19674382-Humans, pubmed-meshheading:19674382-Lithium Compounds, pubmed-meshheading:19674382-Male, pubmed-meshheading:19674382-Middle Aged, pubmed-meshheading:19674382-Remission Induction, pubmed-meshheading:19674382-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Algorithm-guided treatment versus treatment as usual for major depression.
pubmed:affiliation	Department of Psychiatry, National Defense Medical College, Saitama, Japan. aihide@ndmc.ac.jp
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't